Log In
BCIQ
Print this Print this
 

Nanoemulsion-adjuvanted influenza vaccine (NB-1008)

  Manage Alerts
Collapse Summary General Information
Company NanoBio Corp.
DescriptionIntranasal, nanoemulsion-based, adjuvanted seasonal influenza vaccine comprised of Fluzone influenza virus vaccine and adjuvant W805EC
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against seasonal influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today